| Search by tag or site | Login to my blog ? Start my own blog |
 |
Morpheus TradingMajor Market and ETF Trading |
Stalking The SPDR S&P Biotech (XBI)
Following up two days of strong gains, the stock market showed surprising resilience against profit taking yesterday. The major indices opened nearly flat, oscillated in a narrow, sideways range throughout the day, then finished near unchanged levels. The S&P 500 edged 0.1% higher, while both the Nasdaq Composite and Dow Jones Industrial Average advanced 0.2%. The small-cap Russell 2000 fell 0.5%, but its loss was modest relative to the prior day's 3.6% gain. The S&P Midcap 400 was unchanged. All of the main stock market indexes settled in the upper third of their intraday ranges.
Total volume in the NYSE ticked 19% lower, as volume in the Nasdaq dipped 11% below the previous day's level. In both exchanges, turnover trickled in below 50-day average levels. Lighter volume during consolidation days is positive because it tells us traders are not selling into strength while the bulls are taking a rest. In both the NYSE and Nasdaq, advancing volume was roughly on par with declining volume. This further confirmed the bullish consolidation near the highs.
In addition to the Utilities sector that we discussed yesterday, the Biotech Index ($BTK) is another industry showing relative strength to the broad market. After bouncing off support of its 200-day MA, the index broke out above its six-week downtrend line on Wednesday, then closed yesterday at its 50-day MA. The index may take a rest for a few days to absorb its recent gains, but a subsequent breakout above yesterday's high would be bullish. The setup is shown on the daily chart of the $BTK below:
Of the five main biotech ETFs we follow (BBH, IBB, FBT, PBE, and XBI), the SPDR S&P Biotech (XBI) is showing the most relative strength within the sector. Having barely corrected with the broad market over the past month, it is now poised to break out to fresh all-time high. Yesterday, XBI closed just four cents shy of its record closing high. A rally above yesterday's high would trigger a potential long entry. The bullish setup is illustrated on the daily chart of XBI below:
Comparing the charts of the $BTK index and XBI, one will quickly see that XBI is showing relative strength to its underlying index. While the $BTK has just broken out above an intermediate-term downtrend line, XBI it ready to break out to a new high. Within our top-down process of sector trading, we first identify the overall stock market trend, then find the sector index(es) with the most relative strength (or weakness) to the major indices. Upon doing so, we then determine which ETF family is showing the most relative strength to the sector index itself. Comparing charts of all the Biotech ETF families, XBI is the only one near its high. It therefore should gain the most on further strength, while pulling back the least in the event of a market correction. This entire ETF sector trading process is explained in more detail in my new book on ETF trading, scheduled to be published by Bloomberg Press in mid-2008.
With the major indices closing near the flat line, the resistance levels we illustrated in yesterday's commentary remain in effect. Specifically, be sure to monitor price action closely if the Nasdaq Composite approaches its 50-day MA (2,720) or the S&P 50 nears its 200-day MA (1,484). Below, the 20-day MA in both indexes should now act as near-term support. Those levels approximately coincide with yesterday's lows. Until the market proves otherwise, any stocks or ETFs bought should be viewed within the context of playing a short-term bounce within a longer-term downtrend. The overall short-term market trends remain bullish, but the intermediate-term trends are still bearish. A recovery above the 61.8% Fibonacci retracement levels of the entire sell-off could reverse the bearish intermediate-term bias.
Open ETF
positions:
Long - IDU
Short - (none)
NOTE: Regular subscribers to
The Wagner Daily receive daily updates on the open positions above,
as well as new ETF trade setups, including trigger, stop, and target prices.
Intraday e-mail alerts are also sent on as-needed basis.
Deron Wagner is the head trader of Morpheus Capital Hedge Fund and founder of
Morpheus Trading Group (morpheustrading.com),
which he launched in 2001. Wagner appears on his best-selling video, Sector
Trading Strategies (Marketplace Books, June 2002), and is co-author of both The
Long-Term Day Trader (Career Press, April 2000) and The After-Hours Trader
(McGraw Hill, August 2000). Past television appearances include CNBC, ABC, and
Yahoo! FinanceVision. He is also a frequent guest speaker at various trading and
financial conferences around the world. Wagner is currently working on this
third book, scheduled for publication in early 2008.
For a free trial to the full version of The Wagner Daily above, which
includes detailed ETF trade setups and daily position updates, or to learn about
our other newsletters, visit
morpheustrading.com or send an e-mail to
deron@morpheustrading.com.
- Finally, Some Trend Resolution!
- Basic Materials Setting Up For Another Leg Down
- Patience Paying Off
- Short-term Charts Choppy? Try The Weekly Charts.
- Waiting For The Real Direction Of The Market
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
1 Comments:
The page is blank!
<< My Home | TheMoneyBlogs Home